Lookup NU author(s): Professor Fai Ng,
Dr Joseph Guadagno
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Twenty percent of patients with Sjogren’s syndrome experience associated neurological disease.Transverse myelitis (TM) frequently forms part of a neuromyelitis optica spectrum disorder associatedwith the presence of anti-aquaporin 4 (AQP4) antibodies. We report the first described case of a patientwho developed TM and the presence of a newly recognized antibody, anti-myelin oligodendrocyteprotein (MOG), who went on to develop Sjogren’s syndrome. AQP4 and MOG antibodies shouldbe tested to guide prognostically the chances of further relapse as well as the type and duration ofimmunotherapy in patients with coexisting Sjogren's syndrome and TM.
Author(s): Jobling K, Ledingham D, Ng WF, Guadagno J
Publication type: Article
Publication status: Published
Journal: European Journal of Rheumatology
Pages: Epub ahead of print
Online publication date: 06/11/2018
Acceptance date: 30/09/2018
ISSN (print): 2147-9720
ISSN (electronic): 2148-4279
Publisher: Medical Research and Education Association
PubMed id: 30407164
Altmetrics provided by Altmetric